ライフサイエンスコーパス: transbronchial

1 atients with sarcoidosis were studied (eight transbronchial, 27 lymph node, two skin, and two oral mu

2 ical and pathological testing (conjunctival, transbronchial and brain biopsies) to search for causes

3 Either bronchoscopy with transbronchial and endobronchial lung biopsies or endoso

4 ple logistic regression analysis, a positive transbronchial aspirate was associated only with a large

5 choscopy; (2) number, order, and location of transbronchial aspirates and results of on-site evaluati

6 sputum cytologic examination, thoracentesis, transbronchial aspiration, or percutaneous transthoracic

7 gnancy increase the likelihood of a positive transbronchial aspiration; (4) USTBNA exhibits a similar

8 Airway inflammation in transbronchial biopsies (B score) correlated with NT in

9 Transbronchial biopsies (n=104) from 29 human lung trans

10 This retrospective study comprised all transbronchial biopsies (TBB) obtained during the first

11 Histology of transbronchial biopsies (TBB) yields little insight, and

12 infiltration in alveolar tissue samples from transbronchial biopsies (TBBs).

13 evaluation and fiberoptic bronchoscopy with transbronchial biopsies and bronchoalveolar lavage exclu

14 Transbronchial biopsies are insufficiently sensitive to

15 CCSP-positive cells were assessed in transbronchial biopsies at 1 and 3 months.

16 Seventy-seven patients had transbronchial biopsies demonstrating BALT.

17 Applying this approach to all 896 transbronchial biopsies distinguished 3 groups: no rejec

18 levels from 184 participants at the time of transbronchial biopsies during their first-year post-tra

19 Transbronchial biopsies from 29 bronchoscopic procedures

20 Bronchoalveolar lavage (BAL) and transbronchial biopsies from 351 human immunodeficiency

21 Transbronchial biopsies from all lung transplant recipie

22 Longitudinal analysis of transbronchial biopsies from human lung transplant recip

23 rway gene expression changes not apparent in transbronchial biopsies in this cohort.

24 CCSP+ve cells in transbronchial biopsies increased at 3 months only in LT

25 Transbronchial biopsies of patients receiving single lun

26 Retrospective chart review of all transbronchial biopsies performed within the first 2 yea

27 ular antigen-staining and rare bacilli while transbronchial biopsies showed granular antigen-staining

28 d for a similar molecular ABMR-like state in transbronchial biopsies using gene expression microarray

29 Transbronchial biopsies were also obtained when possible

30 Endobronchial and transbronchial biopsies were performed in selected patie

31 All transbronchial biopsies were regraded 0 to 4 for acute p

32 c diagnoses were made with 29 (34.9%) of the transbronchial biopsies, and patient management was chan

33 For messenger RNA in transbronchial biopsies, trends (p > 0.05 and <or= 0.10)

34 A expression from small airway brushings and transbronchial biopsies, using RNAseq and digital RNA co

35 red with spirometry and routine surveillance transbronchial biopsies.

36 oscopy with bronchoalveolar lavage (BAL) and transbronchial biopsies.

37 by HRCT, whereas 35.2% had abnormalities on transbronchial biopsies.

38 Ab was determined at the same frequency with transbronchial biopsies.

39 d on airway brushes outperformed those using transbronchial biopsies.

40 of humoral immunity is a frequent finding on transbronchial biopsies.

41 onventional methods [BAL microbiological and transbronchial biopsy (TBB) analyses].

42 ografts using endobronchial biopsy (EBB) and transbronchial biopsy (TBB) from 22 lung transplant pati

43 study of consecutive patients who underwent transbronchial biopsy (TBBx) for evaluation of periphera

44 Descriptions of eosinophils in transbronchial biopsy (TBBx) pathology reports after lun

45 She was a former smoker with a prior transbronchial biopsy for a pulmonary nodule that was ne

46 ly because of the risks and insensitivity of transbronchial biopsy for detecting ACR.

47 way endobronchial and distal alveolar tissue transbronchial biopsy in a random order at 4:00 P.M. and

48 way endobronchial and distal alveolar tissue transbronchial biopsy in a random order at 4:00 P.M. and

49 tologic associations with BALT identified on transbronchial biopsy in human lung allograft recipients

50 Transbronchial biopsy is performed, and pathology yields

51 the possibility that the presence of BALT on transbronchial biopsy may be part of the evolution of im

52 ance and 146 patients who underwent ENB with transbronchial biopsy of a lung lesion between 2013 and

53 bronchoscopist improved the success rate of transbronchial biopsy of subcarinal and aortopulmonary l

54 In August X year, we performed a transbronchial biopsy of the right upper lung.

55 obtained by clinically indicated surgical or transbronchial biopsy or cryobiopsy for pathology.

56 esently, histologic examination of tissue by transbronchial biopsy remains as the definitive diagnost

57 Transbronchial biopsy revealed adiaspores of the fungus

58 se samples (from 25 patients), corresponding transbronchial biopsy samples were available for CMV imm

59 Pathologic correlation between the transbronchial biopsy specimens and lung tissue obtained

60 sults were obtained in the endobronchial and transbronchial biopsy specimens, which consistently show

61 ults were compared with lavage and endo- and transbronchial biopsy studies in normal controls and pat

62 apeutic aspiration of airway secretions, and transbronchial biopsy to diagnose parenchymal lung disor

63 Transbronchial biopsy to sample lymph nodes and tumors t

64 Transbronchial biopsy was performed in 36 patients, of w

65 aluated by clinical history and examination, transbronchial biopsy, and high-resolution lung computed

66 We evaluated complications associated with transbronchial biopsy, diagnostic yield of the procedure

67 stable or improving in the weeks leading to transbronchial biopsy.

68 esence or absence of acute lung rejection on transbronchial biopsy.

69 dpoint was the incidence of ACR on follow-up transbronchial biopsy.

70 lop once disease recurrence had been seen on transbronchial biopsy.

71 s found to correlate with acute rejection by transbronchial biopsy.

72 treatable infection was diagnosed only with transbronchial biopsy.

73 Procuring a good quality transbronchial-biopsy sample is essential for diagnosing

74 Insufficient transbronchial-biopsy samples are graded "AX." We hypoth

75 Rationale: Transbronchial cryobiopsy (TBCB) for the diagnosis of in

76 Messenger RNA in transbronchial lung biopsies and bronchoalveolar lavage

77 Histologic analysis of transbronchial lung biopsies demonstrated a few eosinoph

78 s, using bronchoalveolar lavage and repeated transbronchial lung biopsies to determine progression to

79 Bronchoscopy with transbronchial lung biopsies, the current diagnostic sta

80 acute rejection is diagnosed with the use of transbronchial lung biopsies, which are invasive, expens

81 tient management based on the results of the transbronchial lung biopsies.

82 Bronchoscopy and transbronchial lung biopsy (TBLB) are the gold standard

83 id granuloma with noncaseating necrosis from transbronchial lung biopsy (TBLB) specimen, increasing o

84 ocyte cellular analysis, and suggestions for transbronchial lung biopsy and surgical lung biopsy were

85 The pathology of transbronchial lung biopsy and the findings of bronchoal

86 omography findings alone and for considering transbronchial lung biopsy as a diagnostic tool.

87 Transbronchial lung biopsy can be performed with an acce

88 o had diagnostic lung pathology as well as a transbronchial lung biopsy for molecular testing with En

89 Eighty-three transbronchial lung biopsy procedures were performed in

90 umonia, or sepsis could be attributed to the transbronchial lung biopsy procedures.

91 r identified usual interstitial pneumonia in transbronchial lung biopsy samples from 49 patients with

92 Three to five transbronchial lung biopsy samples were collected from a

93 machine learning algorithm in less-invasive transbronchial lung biopsy samples.

94 of 45 tissue remodeling-associated genes in transbronchial lung biopsy specimens from two cohorts wi

95 A "molecular diagnosis of UIP" in transbronchial lung biopsy, the Envisia Genomic Classifi

96 allium scanning, bronchoalveolar lavage, and transbronchial lung biopsy.

97 Transbronchial lung cryobiopsy (TBLC) is a novel techniq

98 Rationale: Transbronchial lung cryobiopsy (TBLC) is an emerging tec

99 ationale: The diagnostic concordance between transbronchial lung cryobiopsy (TBLC)-versus surgical lu

100 onditional recommendation was made to regard transbronchial lung cryobiopsy as an acceptable alternat

101 aining BAL for lymphocyte cellular analysis, transbronchial lung cryobiopsy, and surgical lung biopsy

102 Questions about transbronchial lung cryobiopsy, genomic classifier testi

103 gest there is a plateau in yield after seven transbronchial needle aspirates, which may be sufficient

104 tolerance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) are based m

105 include endobronchial ultrasonography-guided transbronchial needle aspiration (EBUS-TBNA) biopsies of

106 l disease on endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients

107 volvement by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in stage-II

108 The role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the clin

109 Real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an estab

110 Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is becoming

111 Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is establis

112 Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasi

113 em to either endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) or conventi

114 mputerized tomography (CT) of the chest with transbronchial needle aspiration (TBNA) in the staging o

115 Transbronchial needle aspiration (TBNA) of intrathoracic

116 In multivariate analysis, peripheral transbronchial needle aspiration (TBNA), larger lesion s

117 chieve a diagnosis as compared with standard transbronchial needle aspiration (TBNA).

118 ospectively confirm that ultrasound-directed transbronchial needle aspiration (USTBNA) results in: (1

119 to optimize yield, we prospectively studied transbronchial needle aspiration and the sequential effe

120 specimens acquired by endoscopic ultrasound transbronchial needle aspiration are sufficient for mole

121 ed to assess endobronchial ultrasound-guided transbronchial needle aspiration as an initial investiga

122 Transbronchial needle aspiration guided by endobronchial

123 (1) in the setting of on-site cytopathology, transbronchial needle aspiration has a high sensitivity,

124 Transbronchial needle aspiration has emerged as a key te

125 Concurrently, endoscopic ultrasound transbronchial needle aspiration has emerged as an accur

126 Endobronchial ultrasonography-guided transbronchial needle aspiration mediastinal staging (EB

127 A cytologically positive transbronchial needle aspiration occurred with the first

128 ved from CT, endobronchial ultrasound-guided transbronchial needle aspiration, PET, and brain MRI) by

129 1 systematic endobronchial ultrasound-guided transbronchial needle aspiration-negative, and 1 without

130 rgical exploration in patients with negative transbronchial needle aspiration; (4) sensitivity, speci

131 cisplatin by endobronchial ultrasound-guided transbronchial needle injection (EBUS-TBNI) has recently

132 chial lung tumor following ultrasound-guided transbronchial needle injection (EBUS-TBNI).

133 me reduction procedure for emphysema whereby transbronchial passages into the lung are created to rel

134 ome nanoparticle-enabled fluorescence-guided transbronchial photothermal therapy (PTT) of peripheral

135 Porphysomes also enhanced the efficacy of transbronchial PTT significantly and resulted in selecti

136 roviding real-time fluorescence guidance for transbronchial PTT.

137 s of concurrently obtained endobronchial and transbronchial/surgical biopsy tissue from 20 individual